InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Zante Greg, Chief Financial Officer. Officer active across 1 company, notably Viking Therapeutics, Inc.. Cumulatively, 18 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €624k. History available since 28 September 2021. The latest transaction was disclosed on 28 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Zante Greg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-324447:0
21,217 shares@ US$33.47040.017% mcap56.2% of flowCommon Stock, par value $0.00001 per shareSEC:0001193125-26-324447:1
41,000 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-26-003116:0
11,117 shares0Common Stock, par value $0.00001 per shareSEC:0001193125-25-254298:0
7,667 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-093792:0
44,533 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-25-002485:0
12,750 shares@ US$7.7718.4% of flowCommon Stock, par value $0.00001 per shareSEC:0000950170-24-117885:0
6,667 shares0Common Stock, par value $0.00001 per shareSEC:0000950170-24-088538:0
4,249 shares@ US$4.683.7% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-24-005522:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-005116:0
31,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-004231:0
28,334 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-24-000929:0
7,500 shares@ US$13.0718.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024722:0
3,242 shares@ US$7.774.6% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-024227:0
32,000 shares@ US$8.5250.0% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-23-022398:0
20,233 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-23-001343:0
3,097 shares@ US$4.881.2% of flowCommon Stock, par value $0.00001 per shareSEC:0001209191-22-001988:0
6,667 shares0Common Stock, par value $0.00001 per shareSEC:0001209191-21-058246:0
18 of 18 declarations
About Zante Greg
ZANTE GREG is Directeur Financier at Viking Therapeutics, Inc. He appears in 16 filings in total, and across the recent sample of 16 filings, both buy and sell amounts are 0 EUR, with filings observed between 2021-09-30 and 2026-01-05. The most frequent transaction nature is Attribution.
